featured
Safety and Efficacy of VP-102, a Proprietary, Drug–Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol 2020 Sep 23;[EPub Ahead of Print], LF Eichenfield, W McFalda, B Brabec, E Siegfried, P Kwong, M McBride, J Rieger, C Willson, M Davidson, P BurnettFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.